Disruption of sphingolipid biosynthetic gene IPT1 reduces Candida albicans adhesion and prevents activation of human gingival epithelial cell innate immune defense

References

• Baccaglini L, Atkinson J, Patton L, . Management of oral lesions in HIV-positive patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103(S50): e1–23.
   PubMedGoogle Scholar
• Laudenbach J, Epstein J. Treatment strategies for oropharyngeal candidiasis. Expert Opin Pharmacother 2009; 10: 1413–1421.
   PubMed Web of Science ®Google Scholar
• Guani-Guerra E, Santos-Mendoza T, Lugo-Reyes SO, Teran LM. Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin Immunol 2010; 135: 1–11.
   PubMed Web of Science ®Google Scholar
• Walsh T, Gonzalez C, Piscitelli S, . Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis. J Clin Microbiol 2000; 38: 2369–2373.
   PubMed Web of Science ®Google Scholar
• Sheft D, Shrago G. Esophageal moniliasis. The spectrum of the disease. JAMA 1970; 213: 1859–1862.
   PubMed Web of Science ®Google Scholar
• Thom K, Forrest G. Gastrointestinal infections in immunocompromised hosts. Curr Opin Gastroenterol 2006; 22: 18–23.
   PubMed Web of Science ®Google Scholar
• Park H, Liu Y, Solis N, . Transcriptional responses of Candida albicans to epithelial and endothelial cells. Eukaryot Cell 2009; 8: 1498–1510.
   PubMed Web of Science ®Google Scholar
• Zakikhany K, Naglik JR, Schmidt-Westhausen A, . In vivo transcript profiling of Candida albicans identifies a gene essential for inter-epithelial dissemination. Cell Microbiol 2007; 9: 2938–2954.
   PubMed Web of Science ®Google Scholar
• Parks L, Casey W. Physiological implications of sterol biosynthesis in yeast. Annu Rev Microbiol 1995; 49: 95–116.
   PubMed Web of Science ®Google Scholar
• Dickson R, Lester R. Metabolism and selected functions of sphingolipids in the yeast Saccharomyces cerevisiae. Biochim Biophys Acta 1999; 1438: 305–321.
   PubMed Web of Science ®Google Scholar
• Lester R, Dickson R. Sphingolipids with inositolphosphatecontaining head groups. Adv Lipid Res 1993; 26: 253–274.
   PubMedGoogle Scholar
• Bagnat MKS, Shevchenko A, Shevchenko A. Simons K. Lipid rafts function in biosynthetic delivery of proteins to the cell surface in yeast. Proc Natl Acad Sci USA 2000; 97: 3254–3259.
   PubMed Web of Science ®Google Scholar
• Dongari-Bagtzoglou A, Fidel PJ. The host cytokine responses and protective immunity in oropharyngeal candidiasis. J Dent Res 2005; 84: 966–977.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay K, Prasad T, Saini P, . Membrane sphingolipidergosterol interactions are important determinants of multidrug resistance in Candida albicans. Antimicrob Agents Chemother 2004; 48: 1778–1787.
   PubMed Web of Science ®Google Scholar
• Wells G, Dickson R, Lester L. Isolation and composition of inositolphosphorylceramide-type sphingolipids of hyphal forms of Candida albicans. J Bacteriol 1996; 178: 6223–6226.
   PubMed Web of Science ®Google Scholar
• Dickson R, Nagiec E, Wells G, Nagiec M, Lester R. Synthesis of mannose-(inositol-P)2-ceramide, the major sphingolipid in Saccharomyces cerevisiae, requires the IPT1 (YDR072c) gene. J Biol Chem. 1997; 272: 29620–29625.
   PubMed Web of Science ®Google Scholar
• Prasad T, Saini P, Gaur NA, . Functional analysis of CaIPT1, a sphingolipid biosynthetic gene involved in multidrug resistance and morphogenesis of Candida albicans. Antimicrob Agents Chemother 2005; 49: 3442–3452.
   PubMed Web of Science ®Google Scholar
• Liew FY, Xu D, Brint EK, O'Neill LA. Negative regulation of Toll-like receptor-mediated immune responses. Nat Rev Immunol 2005; 5: 446–458.
   PubMed Web of Science ®Google Scholar
• Akira S, Takeda K. Toll-like receptor signaling. Nat Rev Immunol 2004; 4: 499–511.
   PubMed Web of Science ®Google Scholar
• Bahri R, Saidane-Mosbahi D, Rouabhia M. Candida famata modulates toll-like receptor, beta-defensin, and proinflammatory cytokine expression by normal human epithelial cells. J Cell Physiol 2010; 222: 209–218.
   Web of Science ®Google Scholar
• Jouault T, Ibata-Ombetta S, Takeuchi O, . Candida albicans phospholipomannan is sensed through Toll-like receptors. J Infect Dis, 2003; 188: 165–172.
   PubMed Web of Science ®Google Scholar
• Levitz SM. Interactions of Toll-like receptors with fungi. Microbes Infect 2004; 6: 1351–1355.
   PubMed Web of Science ®Google Scholar
• Pivarcsi A, Bodai L, Rethi B, . Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol 2003; 15: 721–730.
   PubMed Web of Science ®Google Scholar
• Tjärnlund A, Guirado E, Julián E, Cardona PJ, Fernández C. Determinant role for Toll-like receptor signalling in acute mycobacterial infection in the respiratory tract. Microbes Infect 2006; 8: 1790–1800.
   PubMedGoogle Scholar
• Decanis N, Savignac K, Rouabhia M. Farnesol promotes epithelial cell defense against Candida albicans through Toll-like receptor 2 expression, interleukin-6 and human beta-defensin 2 production. Cytokine 2009; 45: 132–140.
   PubMed Web of Science ®Google Scholar
• Mostefaoui Y, Bart C, Frenette M, Rouabhia M. Candida albicans and Streptococcus salivarius modulate IL-6, IL-8, and TNF-alpha expression and secretion by engineered human oral mucosa cells. Cell Microbiol 2004; 6: 1085–1096.
   PubMed Web of Science ®Google Scholar
• Joly S, Organ CC, Johnson GK, McCray PB, Jr., Guthmiller JM. Correlation between beta-defensin expression and induction profiles in gingival keratinocytes. Mol Immunol 2005; 42: 1073–1084.
   PubMedGoogle Scholar
• Weinberg A, Krisanaprakornkit S, Dale BA. Epithelial antimicrobial peptides: review and significance for oral applications. Crit Rev Oral Biol Med 1998; 9: 399–414.
   PubMedGoogle Scholar
• Feng Z, Jiang B, Chandra J, . Human beta-defensins: differential activity against Candidal species and regulation by Candida albicans. J Dent Res 2005; 84: 445–450.
   PubMed Web of Science ®Google Scholar
• Tanida T, Okamoto T, Okamoto A, . Decreased excretion of antimicrobial proteins and peptides in saliva of patients with oral candidiasis. J Oral Pathol Med 2003; 32: 586–594.
   PubMedGoogle Scholar
• Sawaki K, Mizukawa N, Yamaai T, Fukunaga J, Sugahara T. Immunohistochemical study on expression of alpha-defensin and beta-defensin-2 in human buccal epithelia with candidiasis. Oral Dis 2002; 8: 37–41.
   PubMedGoogle Scholar
• Rouabhia M, Deslauriers N. Production and characterization of an in vitro engineered human oral mucosa. Biochem Cell Biol 2002; 80: 189–195.
   Google Scholar
• Rouabhia M, Ross G, Pagé N, Chakir J. Interleukin-18 and gamma interferon production by oral epithelial cells in response to exposure to Candida albicans or lipopolysaccharide stimulation. Infect Immun 2002; 70: 7073–7080.
   PubMed Web of Science ®Google Scholar
• Richardson M, Rautemaa R. How the host fights against Candida infections. Front Biosci 2009; 14: 4363–4375.
   Web of Science ®Google Scholar
• Hearn J, Lester R, Dickson R. The uracil transporter Fur4p associates with lipid rafts. J Biol Chem 2003; 278: 3679–3686.
   PubMedGoogle Scholar
• Vylkova S, Nayyar N, Li W, Edgerton M. Human beta-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption. Antimicrob Agents Chemother 2007; 51: 154–161.
   PubMed Web of Science ®Google Scholar